Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers

SIMPLE SUMMARY: About 30% of patients with papillary thyroid cancer (PTC) experience persistent/recurrent disease within 10 years after an initial treatment, serum thyroglobulin (Tg) representing the gold standard for surveillance. However, the measurement of serum Tg is unreliable in the presence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Campennì, Alfredo, Aguennouz, M’hammed, Siracusa, Massimiliano, Alibrandi, Angela, Polito, Francesca, Oteri, Rosaria, Baldari, Sergio, Ruggeri, Rosaria Maddalena, Giovanella, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688692/
https://www.ncbi.nlm.nih.gov/pubmed/36428713
http://dx.doi.org/10.3390/cancers14225620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688692/
https://www.ncbi.nlm.nih.gov/pubmed/36428713
http://dx.doi.org/10.3390/cancers14225620

Ejemplares similares